Cancer & the Immune System: The Vital Connection | CRI
2.1 Innate Immunity: Our First Line of Defense; 2.2 Adaptive Immunity: Learning the Enemy’s Tricks; 2.3 Inflammation: Linking Innate and Adaptive Immunity; 2.4 The Humoral Immune Response: Making Antibodies; 2.5 The Cellular Immune Response: Making “Killer” T Cells; 2.6 Tolerance and the Problem of Autoimmunity; Part 3: Cancer immunotherapy
Cancer Immunology Research Journal | CRI
In 2001, the Cancer Research Institute (CRI), along with the Academy of Cancer Immunology, launched an important new journal, Cancer Immunity Research Journal. Led by inaugural Editor-in-Chief Dr. Lloyd J. Old, a world-renowned cancer immunologist, the journal was, at the time, the only journal devoted to all aspects of cancer immunology.
CRI Peptide Database - Cancer Research Institute
As part of the Cancer Research Institute’s former open access journal, Cancer Immunity, the Peptide Database became an important tool for its readers. “The database is primarily designed to provide the scientific community with an open view of the nature and diversity of the tumor antigens available to date for cancer immunotherapy,” says ...
Immunotherapy at a Glance | Cancer Research Institute
The immune system can adapt continuously and dynamically to keep pace with cancer’s rate of mutation and growth. Specifically, it targets constantly mutating cancer cells while sparing healthy cells. Immunotherapy is a “living drug” that remains active thanks to the immune system’s “memory,” enabling it to keep up and even outpace ...
CICON24 Recap: Key Breakthroughs and Bold Conversations …
2024年9月17日 · Day one concluded with a deep dive into tertiary lymphoid structures (TLS) and their role in regulating anti-cancer immunity. CRI CLIP Investigator Nir Hacohen, PhD, from Massachusetts General Hospital and Wolf Hervé Fridman, MD, PhD, from Cordeliers Research Center in Paris, explained how TLS shapes the tumor’s response to immunotherapy.
How does the immune system work? - Cancer Research Institute
2019年4月30日 · The body’s powerful immune system can protect us against cancer, and is capable of eliminating tumors that have formed. Immunotherapy is a class of treatments that taps into the immune system’s power. By doing so, immunotherapy can enable the immune system to target and potentially cure all types of cancer, ultimately saving more lives.
Immunotherapy for Pancreatic Cancer - Cancer Research Institute
Pancreatic cancer is one of the world’s most lethal cancers and the third-leading cause of cancer-related death in the United States. Each year, an estimated 460,000 people globally—and 64,000 in the U.S.—are diagnosed with pancreatic cancer, and it causes approximately 430,000 deaths worldwide and 50,000 in the U.S.
William B. Coley Award - Cancer Research Institute
However, certain subsets of macrophages are also capable of behavior that suppresses antitumor immunity and promotes the development and progression of cancer. Among her contributions are discoveries that revealed the embryonic origin of macrophages as well as the local factors that maintain their distinct populations within tissues.
Ira Mellman, PhD - Cancer Research Institute
In any one patient, the [cancer immunity] cycle can fail at any one of a number of points. And if we can figure out which is the failure point for any one patient, then we can figure out what it is we have to do for that patient.
Ira Mellman Receives 2022 AACR-CRI Lloyd J. Old Award in Cancer …
2022年4月1日 · Ira Mellman, PhD, a longtime member of the Cancer Research Institute (CRI) Scientific Advisory Council and current vice president of cancer immunology at Genentech, has been named the recipient of the 2022 Lloyd J. Old Award in Cancer Immunology, presented on behalf of the American Association for Cancer Research (AACR) and CRI.
跳至内容